Busulfan

	Busulfan
Trade Name	Busulfex
Orphan Indication	As preparative therapy in the treatment of malignancies with bone marrow transplantation
USA Market Approval	USA
USA Designation Date	1994-07-28 00:00:00
Sponsor	Otsuka Pharmaceutical Company;Tokyo;